期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
幽门螺杆菌胞内感染机制与临床思考
1
作者 唐智慧 符立发 +3 位作者 刘人捷 陈昱作 别明江 王保宁 《四川大学学报(医学版)》 CAS CSCD 北大核心 2023年第6期1300-1305,共6页
长期以来,幽门螺杆菌(Helicobacter pylori, H. pylori)被认为是一种胞外菌。最近研究表明,H. pylori能进入到宿主细胞内,逃避宿主免疫系统攻击和药物的杀伤,形成稳定的胞内生态位,并可以重新释放到细胞外导致反复感染。H. pylori胞内... 长期以来,幽门螺杆菌(Helicobacter pylori, H. pylori)被认为是一种胞外菌。最近研究表明,H. pylori能进入到宿主细胞内,逃避宿主免疫系统攻击和药物的杀伤,形成稳定的胞内生态位,并可以重新释放到细胞外导致反复感染。H. pylori胞内感染引起细胞信号传导和代谢改变,可能与肿瘤的发生和发展密切相关,为H. pylori的临床根除治疗带来新的挑战。本文从临床的角度对H. pylori实现宿主生物屏障突破、免疫逃逸、抗自噬等胞内感染机制进行了综述,并对H.pylori的临床防治策略、胞内衍化以及对宿主细胞的损伤等问题进行了思考和展望。 展开更多
关键词 幽门螺杆菌 胞内感染机制 临床思考 综述
原文传递
Anti-bacterial and anti-viral effects of Fengreqing oral liquid(风热清口服液) in vitro and in vivo
2
作者 LIU Jie chen yuzuo +3 位作者 OU Kaixi WANG Baoning PENG Fu YU chenghao 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2021年第4期530-538,共9页
OBJECTIVE:To investigate the anti-bacterial and anti-viral effects of Fengreqing oral liquid(风热清口服液,FRQ)in vitro and in vivo.METHODS:The minimum inhibitory concentrations of Fengreqing Oral Liquid against six gr... OBJECTIVE:To investigate the anti-bacterial and anti-viral effects of Fengreqing oral liquid(风热清口服液,FRQ)in vitro and in vivo.METHODS:The minimum inhibitory concentrations of Fengreqing Oral Liquid against six gram-positive bacteria(Staphylococcus aureus,Streptococcus mutans,Peptostreptococcus anaerobius,Hemolytic streptococcus,Streptococcus pneumoniae,Klebsiella pneumoniae),seven gram-negative bacteria(Escherichia coli,Actinobacillus actinomycetemcomitans,Porphyromonas gingivalis,Haemophilus influenzae,Helicobacter pylori,Pseudomonas aeruginosa,Gardnerella vaginalis)and Candida albicans were detected by the paper disc diffusion method.The inhibition rate of A/Puerto Rico/8/34(H1N1)(PR8)influenza virus in different concentrations of Fengreqing oral solution was detected by chicken embryo method.CCK8 method was used to detect the half-cell infection of RSV,VSV and CVB3.The effect of FRQ on the survival curve of mice was detected by using co-infection model of Streptococcus pneumoniae and influenza virus.RESULTS:In vitro,FRQ can inhibit Actinobacillus actinomycetemcomitans,Helicobacter pylori,Gardnerella vaginalis,Staphylococcus aureus,Streptococcus mutans and Streptococcus pneumoniae and has an antiviral effect on the envelope virus H1N1.In vivo,Fengreqing oral solution had therapeutic effect on influenza-Streptococcus pneumoniae co-infection in mice,significantly improving the survival rate of mice.The medium dose and low dose FRQ significantly prolonged the survival time of mice.CONCLUSION:FRQ has good anti-bacterial and anti-viral effects in vivo and in vitro. 展开更多
关键词 influenza A virus H1N1 subtype gram-positive bacteria gram-negative bacteria anti-bacterial agents antiviral agents Fengreqing oral liquid
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部